pharmaphorum

AUGUST 16, 2021

UK psychedelic medicine specialist Beckley Psytech has raised an impressive £58 million (around $80 million) in an oversubscribed second-round financing that will help fund clinical development of its psilocybin-based therapies. The Oxford-based company had originally hoped to raise $50 million from the series B, and the scale of the financing is further evidence that repurposing psychedelic compounds as potential therapies for neuro-psychiatric disorders is a hot topic in biopharma.

Compounding 135

Compounding 135

Fierce Healthcare

AUGUST 20, 2021

Google says health projects will continue even as it unwinds dedicated health division. hlandi. Fri, 08/20/2021 - 19:08.

145

145

Outsourcing Pharma

AUGUST 19, 2021

The US Food and Drug Administration continues to review potential preventatives and treatments for the virus, and to offer advice to life-sciences professionals and civilians alike.

FDA 98

FDA 98

Pharma Marketing Network

AUGUST 18, 2021

SAVE THE DATE – PMN Fall 2021 Summit: Pharma-Marketing Innovations & Trends of 2021 | SEP. 16th, 12:00PM – 1:30PM EST. SAVE YOUR SEAT TODAY. Telehealth: Is It Here to Stay? Once considered a novelty, over the past 18 months, Telehealth has risen to a prominent position in the continuum of care. Pharmaceutical brands must adapt to this new modality and pivot their promotional efforts to ensure that they can leverage the Telehealth channel effectively.

98

98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 16, 2021

Health Canada has started a rolling review of Merck & Co’s molnupiravir, an oral antiviral therapy treatment for COVID-19 partnered with Ridgeback Biotherapeutics. The Canadian regulator will start reviewing early safety, quality and efficacy data for the drug while late-stage clinical trials are still underway, in the hope of approving the drug quickly of results are positive.

Hospitals 128

Hospitals Vaccines FDA 128

Fierce Healthcare

AUGUST 19, 2021

Physician pay remained stagnant while productivity slumped in 2020, new survey finds. agliadkovskaya. Thu, 08/19/2021 - 19:00.

136

136

The Infectious Pharmacist

AUGUST 20, 2021

Photo by Skitterphoto on Pexels.com. In Booster Doses – Part 1 I wrote about some of the basics of booster doses and the need for “additional” doses (not booster doses) in patients with compromised immune systems. Today I’m going to talk about some of the rationale behind booster doses in patients with healthy immune systems. At the bottom of this post is a list of some background posts and definitions that may be useful.

Vaccines 52

Vaccines Immunization Nursing Homes Hospitals 52

pharmaphorum

AUGUST 19, 2021

Novartis’ Rydapt has become the first and only licensed treatment for rare and life-threatening blood disorder systemic mastocytosis (SM) to be cleared for routine NHS use, after getting a green light from NICE. The decision means around 170 people with advanced SM in England and Wales will be eligible for treatment with oral, twice-daily drug, which since 2018 has also been cleared for NHS treatment of a form of acute myeloid leukaemia.

124

124

Fierce Healthcare

AUGUST 18, 2021

Biden administration to invest $19M to expand telehealth in rural, underserved areas. hlandi. Wed, 08/18/2021 - 08:15.

138

138

Outsourcing Pharma

AUGUST 17, 2021

A leader from Veeva Systems shares perspective on what factors are impacting clinical trial data management, and how the industry can adapt to the changes.

103

103

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

The Infectious Pharmacist

AUGUST 19, 2021

Photo by George Becker on Pexels.com. The most recurring question I get is a variant (see what I did there?) of “What about booster doses?”. A lot of complexity and potential for misunderstanding is built into that seemingly simple question. As my initial writing on this topic got longer and longer, I realized it was time for another 1980s style mini-series of blog posts.

Immunization 52

Immunization Vaccines Hospitals FDA 52

pharmaphorum

AUGUST 17, 2021

Rapid advances in the use of artificial intelligence (AI) in healthcare and medicines development are at risk of outstripping current regulatory frameworks, according to a new report. The International Coalition of Medicines Regulatory Authorities (ICMRA) has recommended that a new permanent working group be set up to keep tabs on the use of AI and make sure that regulations can accommodate new developments.

Documentation 116

Documentation Pharmaceutical Companies Pharmaceutical Companies FDA 116

Fierce Healthcare

AUGUST 17, 2021

Maven Clinic nabs $110M funding round and a boost from Oprah to reach unicorn status. hlandi. Tue, 08/17/2021 - 12:50.

137

137

Outsourcing Pharma

AUGUST 18, 2021

A representative from Clarivate explains how supply chain vulnerabilities can hurt stakeholders, including patientsâand how one solution can close the gap.

96

96

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

The Physician Pharmacist

AUGUST 15, 2021

Applying to medical school is no easy task, but neither is making it through pharmacy school! If you are reading this right now, then you are investigating the same calling I experienced several years ago. Every pharmacy student plays with the fantasy of going to medical school and unfortunately most will never get further than that. I am here to share my insider tips and tricks to optimize your application.

Medical Schools 52

Medical Schools 52

pharmaphorum

AUGUST 15, 2021

In the latest episode of the podcast Dominic Tyer speaks with Dr Maria Ines ‘Mari’ Mitrani, chief science officer at the clinical-stage biopharmaceutical company Organicell Regenerative Medicine. They looked at the development of regenerative medicine and where Organicell hopes to add to that field. Then, with the company pivoting to try and help tackle Covid, they also discussed how that change was made possible and where Organicell’s focus will be.

111

111

Fierce Healthcare

AUGUST 20, 2021

NextGen Healthcare founder Razin looks to shake up board to improve company's performance. hlandi. Fri, 08/20/2021 - 12:58.

133

133

Outsourcing Pharma

AUGUST 19, 2021

The digital pathology firm and image-analysis software developer will partner on artificial intelligence based solutions to improve trial decision making.

78

78

Med Ed 101

AUGUST 18, 2021

As one of the few significant new treatment options approved for reducing the risk of cardiovascular events since statins were approved about 30 years ago, when should icosapent ethyl (Vascepa) actually be used? Icosapent ethyl, sold as Vascepa by Amarin, is a purified form of the ethyl ester of eicosapentaenoic acid (EPA) that was approved […].

40

40

pharmaphorum

AUGUST 17, 2021

In latest episode of our Health Innovators video interview series, Dr Paul Tunnah speaks to Daphne Zohar, the co-founder and CEO of PureTech Health. They discuss the publicly-listed biotech’s pipeline projects and focus on the BIG (brain-immune-gut) axis as well as PureTech’s interest in digital therapeutics. Daphne explains how she built an impressive team of board advisors for her company, plus the challenges and experience of fund raising.

Communication 110

Communication Immunization 110

Fierce Healthcare

AUGUST 19, 2021

Insurers take cue from providers, begin requiring vaccines for employees. pminemyer. Thu, 08/19/2021 - 12:32.

Insurance 140

Insurance Vaccines 140

Outsourcing Pharma

AUGUST 18, 2021

The excipients specialist shares findings from its research into the ins and outs of 3D powder bed printed tablets and how it can benefit drug development.

73

73

Med Ed 101

AUGUST 15, 2021

Treatment for patients hospitalized with COVID-19 is continuously evolving. Some medications have proven beneficial over the past year, while others have fallen out of favor. Here we review the most recent guidelines as of August 2021. In short, it is recommended to continue home maintenance medications, provide supportive care for non-severe cases of COVID, and, […].

Hospitals 40

Hospitals 40

pharmaphorum

AUGUST 19, 2021

A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based. The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make its views known. The publication, which is out for public consultation until 15 September, said RCTs played a central role in generating the evidence needed to inform the de

Documentation 105

Documentation Communication 105

Fierce Healthcare

AUGUST 18, 2021

Survey: Nurses largely on board with COVID-19 vaccines but want more info on boosters, long-term safety. dmuoio. Wed, 08/18/2021 - 15:32.

Vaccines 124

Vaccines 124

Outsourcing Pharma

AUGUST 18, 2021

A leader from the excipients firm discusses how ODTs appeal to seniors and patients on the go, and the formulation-related challenges with such tablets.

64

64

Pharma Times

AUGUST 16, 2021

VHL is a rare genetic disease which puts patients at risk of developing benign blood vessel tumours and several cancers

49

49

pharmaphorum

AUGUST 16, 2021

Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2 in people aged over 16, as the US prepares to get its booster campaign underway. The two companies have submitted data from a phase 1 trial in support of the booster dose to the US regulator, and will follow that with filings in Europe and elsewhere in the world in the coming weeks.

FDA 100

FDA Vaccines Immunization 100

Fierce Healthcare

AUGUST 19, 2021

GoodRx reports spike in drug discount subscribers driving 43% revenue growth in Q2. hlandi. Thu, 08/19/2021 - 12:39.

134

134

Outsourcing Pharma

AUGUST 17, 2021

An executive from the digital therapeutics specialist discusses the clinical trial landscape, and how clinical care can yield a number of important benefits.

52

52

Pharma Times

AUGUST 19, 2021

Public consultation launches on proposed changes aiming to provide earlier access to new treatments

52

52

pharmaphorum

AUGUST 20, 2021

Bristol Myers Squibb has exercised an option on an immune-modulating drug candidate developed by UK artificial intelligence specialist Exscientia, paying $20 million for the buy-in as part of their $1.2 billion alliance. The unnamed drug candidate acts on an immunological kinase enzyme, which has proven hard to target using conventional drug discovery techniques because challenges relating to “potency, selectivity, and overall drug-like properties,” according to the partners.

Immunization 98

Immunization 98

Fierce Healthcare

AUGUST 16, 2021

Memorial Health cancels surgeries, reverts to paper records as it responds to cyberattack. hlandi. Mon, 08/16/2021 - 17:20.

130

130

Outsourcing Pharma

AUGUST 17, 2021

This monthâs roundup of equipment, decentralized technology, partnerships and other items includes news from Medidata, PerkinElmer, Syneos and other firms.

52

52